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Background:Deﬁciency of 25-hydroxy vitamin D [25(OH)D] is a treatable condition that has been associatedwith
coronary artery disease andmany of its risk factors. A practical time to assess for 25(OH)D deﬁciency, and to ini-
tiate treatment, is at the time of an acute myocardial infarction(AMI). The prevalence of 25(OH)D deﬁciency and
the characteristics associated with it in patients with acute myocardial infarction are unknown.
Methods: In this study 25(OH)Dwas assessed in 314 subjects enrolled in a Sri Jayadeva Institute of Cardiovascular
Science and Research(SJICS&R). Patients enrolled from December 1, 2011 to February 28, 2012 had serum sam-
ples sent to a centralized laboratory for analysis using the ELECYS assay. Normal 25(OH)D levels are≥30 ng/ml,
and patients with levels b30 and N20 ng/ml were classiﬁed as insufﬁcient and those with levels ≤20 ng/ml as
deﬁcient. Vitamin D and other baseline characteristics were analyzed with T-test and chi-squared test.
Results: Of the 314 enrolled patents, 212 (67.5%) were 25(OH)D deﬁcient and 50(16%) were insufﬁcient, for a
total of 83.5% of patients with abnormally low 25(OH)D levels. No signiﬁcant heterogeneity was observed
among age or gender sub groups but 25(OH)D deﬁciency was more commonly seen in those with lower socio-
economic status, lower activity levels, diabetes, hypercholesterolemia(LDL), hypertriglyceridemia and in
smokers.
Conclusion: Vitamin D deﬁciency is present in most of the patients with acute myocardial infarction and it is as-
sociated with many of its risk factors in our study.
© 2014 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Vitamin D deﬁciency is highly prevalent worldwide [1], and is also
noted to be high in India [2,3]. Low levels of 25(OH)D the principle cir-
culating storage form of vitamin D, is present in as many as one third to
one half of otherwise healthymiddle aged to elderly population [1,4–6].
Limited cutaneous synthesis due to inadequate sun exposure or
pigmented skin and inadequate dietary intake are the principle causes
of low 25(OH)D levels.
Although the best characterised sequelae of vitamin D deﬁciency in-
volve musculoskeletal system, growing evidence suggests that vitamin
D axis affects vascular smoothmuscle cell proliferation [6], endothelium
[7] cardiomyocytes [1,8] inﬂammation, vascular calciﬁcation, renin–
angiotensin system (RAS) [9,10], blood pressure and LVH [10–12] allAS, Renin angiotensin system;
itute of Cardiovascular Science
ogy, Sri Jayadeva Institute of
Jayanagar 9th Block, Bangalore,
1 80 22977422.
is an open access article under the Cofwhich affect the risk of cardiovascular diseases andmyocardial infarc-
tion. However, the prevalence of vitamin D deﬁciency as well as the
characteristics associatedwith it in patients presentingwith acutemyo-
cardial infarction is unknown.
This is a prospective studyundertaken at SJICS&R, Bangalore, India to
describe the prevalence of vitamin D deﬁciency at the time of admission
for acute myocardial infarction.
2. Methods
We evaluated the subjects enrolled in our study. We collected infor-
mation of the patients admitted for AMI through chart abstraction, de-
tailed patient interviews, and serum samples at SJICS&R from
December 1, 2011 to February 28, 2012.
Inclusion criteria for the study are, age ≥ 20 years, biomarker evi-
dence of myocardial injury (elevated troponins or CKMB), supporting
evidence of AMI (eg., prolonged ischemic signs or symptoms, electro-
cardiographic ST-segment changes), and patients presenting within
24 h of symptoms onset. The study sample included 314 patients.
Those patients with prevalent cardiovascular diseases and kidney dis-
eases (serum creatinine N 1.6) were not included in the cohort. All the
participants providedwritten informed consent. Detailedmedical histo-
ry examination and laboratory assessment of vascular risk factors wereC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Vitamin D levels in post-AMI patients.
Table 1
Vitamin D status.
Serum 25 (OH)D (ng/ml) Vitamin D status
≤20 Deﬁcient
21–29 Insufﬁcient
≥30 Sufﬁcient
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marital status, and education. Collected clinical variables included
smoking, alcohol consumption, hypertension, diabetes mellitus,
hypercholesterolemia, peripheral arterial disease, previous stroke, fam-
ily history of coronary artery disease (CAD), chronic lung disease, chron-
ic renal failure, chronic heart failure, previous angina, previous PTCA,
and CABG. Hypertension was deﬁned as systemic BP ≥ 140 mm of hg,
diastolic BP ≥ 90 mm of hg, or use of anti hypertensive therapy [13].
Criteria for diabetes mellitus were fasting glucose ≥ 126 mg/dl or use
of insulin or hypoglycaemicmedications [14]. Current smoking denoted
regular use of cigarettes in the preceding year. Hypercholesterolemia is
deﬁned as total cholesterol N 200 mg % and LDL cholesterol N 100 mg%
[15]. Hypertriglyceridemia is deﬁned as TGL N 150 mg.
The serum samples were obtained as soon as the patient got admit-
ted to the hospital and before initiating medication (treatment). Data
collected included, complete hemogram, random blood sugar, glycosyl-
ated hemoglobin, renal function tests, lipid proﬁle, cardiac enzymes,
troponins, CKMB, calcium, phosphorous and 25 (OH)D levels. The
serum 25(OH)D was determined by ECLIA from Elecsys Analyser. We
classiﬁed the patients as per Table 1 [16–18].
An Elecsys vitamin D total assay is intended for quantitative deter-
mination of the total 25-hydroxy vitamin D in human serum and plas-
ma. The electrochemiluminescence immunoassay “ECLIA” is intended
for use in Elecsys and cobas e immunoassay analysers. Levels of 25
(OH)D and other baseline characteristics were analyzed using T-test
and chi-squared test.3. Results
During the enrolment period of December 1, 2011 to February 28,
2012, 314 patients admitted to SJICS&R Hospital consented to baseline
blood work and had 25 (OH)D levels assessed via ECLIA method.
Themean age for the total population in deﬁcient groupwas 54.09±
12.26 years and for insufﬁcient and sufﬁcient groups was 52.23 ±
12.13 years (Table 2). 82.48% of the enrolled subjects were men and
17.5% were women (Table 2).
No signiﬁcant heterogeneity was observed among age or gender sub
groups, but vitamin D deﬁciency was more commonly seen in patients
with low social support and lower activity level and diabetes (Table 2).Table 2
Univariate association with vitamin D deﬁciency and insufﬁciency or sufﬁciency.
Variable 25 (OH)D (ng/ml) P value
≤20 N20
(n = 202) (n = 112)
Age 54.09 ± 12.26 52.23 ± 12.13 0.198
Men 157 (78%) 102 (91%)
Women 45 (22%) 10 (9%)
Smoking 108 (53%) 46 (41%) 0.035
Alcohol 3 (1%) 4 (4%) 0.230
Diabetes mellitus 101 (50%) 16 (14%) 0.002
Hyper tension 71 (35%) 35 (31%) 0.484
Total cholesterol (high) 146 (72%) 53 (47%) 0.006
HDL (low) 116 (57%) 55 (45%) 0.052
LDL (high) 146 (72%) 73 (65%) 0.190
TGL (high) 109 (54%) 48 (43%) 0.059
Data are expressed as mean ± SD or as number (percentage). Continuous variables were
compared using T-tests. Categorical variables were compared using chi-square test.Vitamin D deﬁciency was also noted in patients with hypercholester-
olemia, hypertriglyceridemia and smokers with AMI (Table 2). At
baseline 212 subjects (67.5%) were found to have 25(OH)D levels ≤
20 ng/ml, which is in the deﬁcient range. Another 50 subjects (16%)
were in the insufﬁcient range, with vitamin D levels of 20 to 30 ng/ml.
Majority of the subjects (83.5%) were in the suboptimal range of
25(OH)D (normal ≥ 30 ng/ml). (Fig 1)4. Discussion
This study evaluated vitamin D status in patients admitted for
AMI at SJICS&R—a tertiary care centre. Our data suggested that there
is high prevalence of vitamin D deﬁciency or insufﬁciency (83.5%) in
AMI patients. This data is consistent with data associating CAD and
many of its risk factors with 25(OH)D deﬁciency [16,19]. Studies have
shown that individuals with vitamin D deﬁciency were at higher risk
of ischemic heart disease [20–22]. There is a signiﬁcant association be-
tween osteoporosis and vascular calciﬁcation and vitamin D levels are
inversely related to vascular calciﬁcation which in turn may affect AMI
risk [23].
Our data also noted that there is more vitamin D deﬁciency in
patients who are having diabetes mellitus, conﬁrming previously
described associations [24]. Vitamin D deﬁciency with dietary calcium
deﬁciency has been associated with impaired fasting glucose and possi-
bly type 2 diabetes mellitus which is a risk factor for cardiovascular dis-
ease [25,26] which possibly explains the increased prevalence of
vitamin D deﬁciency in our diabetic subgroup.
Animal studies have shown that vitamin D regulates RAS by sup-
pressing renin gene expression, deﬁciency leading to increased renin
production and hypertension [27,12], though in our study hypertension
was equally distributed between the two groups.
Skin pigmentation has a vital role in vitamin D production. Darker
skin individuals produce less vitamin D with same ultraviolet B radia-
tion as compared to fairer skin [28]. This explains the higher prevalence
of vitamin D deﬁciency in our cohort as all the study subjects were
Indians with dark skin.
Patients with high cholesterol high triglyceride levels and who
smoke are high risk factors for cardiovascular disease and these are
associated with vitamin D deﬁciency and myocardial infarction.
Other observations made from the study were lower socioeconomic
status patients and sedentary life style were other risk factors for vita-
min D deﬁciency. Low vitamin D levels in lower socioeconomic status
patients may be because of poor dietary intake of nutritional supple-
ments and sedentary patients may have less sun exposure for adequate
25(OH)D production.
Vitamin D can adversely affect many aspects of health, especially
musculoskeletal and immunological function. Although there are no
randomised trials to explain that normalising vitamin D levels will im-
prove cardiovascular health and prognosis, it is reasonable to screen
AMI patients for vitamin D deﬁciency and to correct deﬁcient levels
59S. Karur et al. / IJC Heart & Vessels 3 (2014) 57–59according to nationally established consensus guidelines to optimize
overall health.
Limitations of the study include small number of study group done
especially during the early part of the year. The studywasnot conducted
throughout the year, so that we are unable to comment on the seasonal
variation and its inﬂuence on the vitamin D levels.
Another limitation of the study is lack of an adequate control group
with normal vitamin D levels. Because of large proportion of patients
who were vitamin D deﬁcient or insufﬁcient, we did not have an ade-
quate group for comparison.
5. Conclusions
Vitamin D deﬁciency is present in most of the patients with acute
myocardial infarction and it is associated with many of its risk factors
in our study. Prospective studies are needed to investigate beneﬁts of
screening and treatment of this very common vitamin deﬁciency for
prevention of cardiovascular diseases.
References
[1] HolickMF. Prevalence of vitamin D inadequacy and implication for health.Mayo Clin
Proc 2006;81:355–73.
[2] Harinarayan CV, Ramalakshmi T, Venkataprasad u. High prevalence of low dietary
calcium and low vitamin D status in healthy Indians. Asia Pac J Clin Nutr
2004;13(4):359–64.
[3] Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N, et al. Prev-
alence and signiﬁcance of low 25(OH)D concentration in healthy subjects in Delhi.
Am J Clin Nutr 2000;72:472–5.
[4] Malabanan A, veronikis IE, Holick MF. Redeﬁning vit D insufﬁciency. Lancet
1998;351:805–6.
[5] Chapuy MC, Preziosi P, Maamer M, Arnald S, Galan P, Herebergs S, Mernier PJ.
Prevalence of vit D insufﬁciency in an adult normal population. Osteoporas Int
1997;7:439–43.
[6] Merke J, HoffmanW, Goldsmidt D, Ritz E. Demonstration of 1,25(OH)2 vit D3 receptors
and actions in vascular smooth mussel cells in vitro. Calcif Tissue Int 1987;41:112–4.
[7] Merk J, Milde P, Lewicka S, Hugel U, Klaus G, Mangelsdorf DJ, Haussler MR,
Ranterberg EW, Ritz E. Identiﬁcation and regulation of 1,25(OH)2D3 receptors activ-
ity and biosynthesis of 1,25(OH)2D3; studies in cultured bovine aortic endothelial
cells and human dermal capillaries. J Clin Invest 1989;83:1903–15.
[8] O'Connell TU, Berry JE, Jarris AK, Simpson RU. 1,25,(OH)2D3 regulation of cardiac
myocyte proliferation and hypertrophy. Am J Physiol 1997;272:H1751–8.
[9] Sigmund CD, Okuyama K, Ingelﬁnger J, Jones CA, Mullins JJ, Kane C, et al. Isolation
and characterization of renin-expressing cell lines from transgenic mice containing
a renin-promoter viral oncogene fusion construct. J Biol Chem 1990 Nov
15;265(32):19916–22.[10] Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxy vitamin D(3) is a
negative endocrine regulator of the renin–angiotensin system. J Clin Invest
2002;110:229–38.
[11] Wu J, Garami M, Cao L, Li Q, Gardner DG. 1,25(OH)2D3 suppresses expression and
secretion of ANP from cardiac myocytes. Am J Physiol 1995;268(pt1):E1108–13.
[12] XiangW, Kong J, Chen S, Cao LP, Qiao G, ZhengW, et al. Cardiac hypertrophy in vit D
receptor knockoutmice: role of the systemic and cardiac renin–angiotensin systems.
Am J Physiol Endocrinol Metab 2005;288:E125–32.
[13] Chobamian AV, Ballin Gl, BlackHr, GreenLa, Jl Izzo, JoneDW,MatronWright JT, Roccella
EJ. The seventh report of the Joint Nation Committee on prevention, detection, evalua-
tion and treatment of high blood pressure. Hypertension 2003;42:1206–52.
[14] Report of the expert committee on the diagnosis and classiﬁcation of diabetes
mellitus. Diabetes Care 1997;20:1183–97.
[15] Third report of the National Cholesterol Education Program (NCEP) expert panel on
detection, evaluation and treatment of high blood cholesterol in adults (Adult treat-
ment panel III). NIH publication No. 01-3670; may 2001.
[16] Lee JH, O'Keefe JH, Bell D, Hensrudd DD, Holick MF. Vitamin D deﬁciency: an impor-
tant, common and easily treatable cardiovascular risk factor. J Am Coll Cardiol
2008;52:1949–56.
[17] Bischoff-Ferrari HA, Gioranncci E, Willet WC, Dawson hughes B. Estimation of opti-
mal serum concentrations of 25-hydroxy vitamin D for multiple health outcomes.
Am J Clin Nutr 2006;84:18–28.
[18] ChapuyMC, Preziosi P, Maaner M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of
vitamin D deﬁciency in an adult normal population. Osteoporos Int 1997;7:439–43.
[19] Carl J, LavicMD, John H, LeeMD, Richard V,MilaniMD. Vitamin D and cardiovascular
disease. JACC 2011;58(15):1547–56.
[20] Lund B, Badskjaer J, Lund B, Soerensen OH. Vitamin D and ischemic heart disease.
Horm Metab Res 1978;10(6):553–6.
[21] Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is
inversely associated with plasma 25-hydroxy vitamin D3 levels: a community
based study. Int J Epidemiol 1990;19(3):559–63.
[22] Vik B, Try K, Thelle DS. Forde OH Tromso Heart study; Vitamin D metabolism and
myocardial infarction. Br Med J 1979;2(6183):176.
[23] Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al. Active
serum vitamin D levels are inversely correlated with coronary calciﬁcation. Circula-
tion 1997;96(6):1755–60.
[24] Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum
25-hydroxy vitamin D3 concentrations and prevalence of cardiovascular diseases
among type 2 diabetic patients. Diabetes Care 2006;29:722–4.
[25] Pittas AG, Harris HS, Stark PC, Dawson-Hughes B. The effect of calcium and vitamin D
supplementation on blood glucose and markers of inﬂammation in non diabetic
adults. Diabetes Care 2007;30(4):980–6.
[26] Maghbooli Z, Hossein-Nezhad A, Karimi F, Shafaei AR, Larijani B. Correlation
between vitamin D3 deﬁciency and insulin resistance in pregnancy. Diabetes
Metab Res Rev 2008;24(1):27–32.
[27] Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endo-
crine regulator of the renin angiotensin system and blood pressure. J Steroid
Biochem Mol Biol 2004;89–90(1–5):387–92.
[28] Matsuoka LY, Wortsman J, Hadda JG, Kolm P, Hollis BW. Racial pigmentation and the
cutaneous synthesis of vitamin D. Arch Dermatol 1991;127:536–8.
